Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Crown Bioscience
About
CrownBio is helping provide clarity of action in the fight against cancer and diabetes.
- 251 - 500
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $26.60M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 251 - 500
- Operating Status
- Active
CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a RealityCrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery.Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 23, 2014 | Series D | $26.60M | 1 |
Lilly Asia Ventures
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series D |
